|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Keszei AP, Schouten LJ, Goldbohm RA and
van den Brandt PA: Red and processed meat consumption and the risk
of esophageal and gastric cancer subtypes in The Netherlands Cohort
Study. Ann Oncol. 23:2319–2326. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steevens J, Schouten LJ, Goldbohm RA and
van den Brandt PA: Vegetables and fruits consumption and risk of
esophageal and gastric cancer subtypes in the Netherlands cohort
study. Int J Cancer. 129:2681–2693. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bravi F, Edefonti V, Randi G, et al:
Dietary patterns and the risk of esophageal cancer. Ann Oncol.
23:765–770. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao J, Li L, Wei S, et al:
Clinicopathological and prognostic role of cyclin D1 in esophageal
squamous cell carcinoma: a meta-analysis. Dis Esophagus.
25:520–526. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaminagakura E, Werneck da Cunha I, Soares
FA, Nishimoto IN and Kowalski LP: CCND1 amplification and protein
overexpression in oral squamous cell carcinoma of young patients.
Head Neck. 33:1413–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Troncone G, Volante M, Iaccarino A, et al:
Cyclin D1 and D3 overexpression predicts malignant behavior in
thyroid fine-needle aspirates suspicious for Hurthle cell
neoplasms. Cancer. 117:522–529. 2009.PubMed/NCBI
|
|
9
|
Abramson VG, Troxel AB, Feldman M, et al:
Cyclin D1b in human breast carcinoma and coexpression with cyclin
D1a is associated with poor outcome. Anticancer Res. 30:1279–1285.
2010.PubMed/NCBI
|
|
10
|
Betticher DC, Thatcher N, Altermatt HJ,
Hoban P, Ryder WD and Heighway J: Alternate splicing produces a
novel cyclin D1 transcript. Oncogene. 11:1005–1011. 1995.PubMed/NCBI
|
|
11
|
Li Z, Jiao X, Wang C, et al: Alternative
cyclin D1 splice forms differentially regulate the DNA damage
response. Cancer Res. 70:8802–8811. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai W, Wang ZT, Zhong J and Zhang Y: Lack
of association between Cyclin D1 gene G870A polymorphism and
esophageal cancer: evidence from a meta-analysis. Genet Mol Res.
12:6636–6645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou X, Gu Y and Zhang SL: Association
between p53 codon 72 polymorphism and cervical cancer risk among
Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev.
13:4909–4914. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Little J, Bradley L, Bray MS, et al:
Reporting, appraising, and integrating data on genotype prevalence
and gene-disease associations. Am J Epidemiol. 156:300–310. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau J, Ioannidis JP and Schmid CH:
Quantitative synthesis in systematic reviews. Ann Intern Med.
127:820–826. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
17
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harbord RM, Egger M and Sterne JA: A
modified test for small-study effects in meta-analyses of
controlled trials with binary endpoints. Stat Med. 25:3443–3457.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu C, Lu W, Tan W, et al: Lack of
association between CCND1 G870A polymorphism and risk of esophageal
squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev.
12:1762003.PubMed/NCBI
|
|
21
|
Zhang J, Li Y, Wang R, et al: Association
of cyclin D1 (G870A) polymorphism with susceptibility to esophageal
and gastric cardiac carcinoma in a northern Chinese population. Int
J Cancer. 105:281–284. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Casson AG, Zheng Z, Evans SC, et al:
Cyclin D1 polymorphism (G870A) and risk for esophageal
adenocarcinoma. Cancer. 104:730–739. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Geddert H, Kiel S, Zotz RB, et al:
Polymorphism of p16 INK4A and cyclin D1 in adenocarcinomas of the
upper gastrointestinal tract. J Cancer Res Clin Oncol. 131:803–808.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jain M, Kumar S, Lal P, Tiwari A, Ghoshal
UC and Mittal B: Role of BCL2 (ala43thr), CCND1 (G870A) and FAS
(A-670G) polymorphisms in modulating the risk of developing
esophageal cancer. Cancer Detect Prev. 31:225–232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu G, Cescon DW, Zhai R, et al: p53
Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not
associated with susceptibility to esophageal adenocarcinoma. Dis
Esophagus. 23:36–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kurmano BK, Djansugurova L, Bersimba R, et
al: TP53 Arg72Pro and CCND1 A870G polymorphisms and esophageal
cancer risk. J Life Sci. 4:16–20. 2010.
|
|
27
|
Hussain S, Yuvaraj M, Thakur N, et al:
Association of cyclin D1 gene polymorphisms with risk of esophageal
squamous cell carcinoma in Kashmir Valley: a high risk area. Mol
Carcinog. 50:487–498. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Akbari MR, Malekzadeh R, Shakeri R, et al:
Candidate gene association study of esophageal squamous cell
carcinoma in a high-risk region in Iran. Cancer Res. 69:7994–8000.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Djansugurova LB, Perfilyeva AV, Zhunusova
GS, Djantaeva KB, Iksan OA and Khussainova EM: The determination of
genetic markers of age-related cancer pathologies in populations
from Kazakhstan. Front Genet. 4:702013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hall M and Peters G: Genetic alterations
of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human
cancer. Adv Cancer Res. 68:67–108. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Solomon DA, Wang Y, Fox SR, et al: Cyclin
D1 splice variants. Differential effects on localization, RB
phosphorylation, and cellular transformation. J Biol Chem.
278:30339–30347. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sergentanis TN and Economopoulos KP:
Cyclin D1 G870A polymorphism and breast cancer risk: a
meta-analysis comprising 9,911 cases and 11,171 controls. Mol Biol
Rep. 38:4955–4963. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Comstock CE, Augello MA, Benito RP, et al:
Cyclin D1 splice variants: polymorphism, risk, and isoform-specific
regulation in prostate cancer. Clin Cancer Res. 15:5338–5349. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yaylim-Eraltan I, Arikan S, Yildiz Y, et
al: The influence of cyclin D1 A870G polymorphism on colorectal
cancer risk and prognosis in a Turkish population. Anticancer Res.
30:2875–2880. 2010.PubMed/NCBI
|
|
35
|
Tsai MH, Tsai CW, Tsou YA, Hua CH, Hsu CF
and Bau DT: Significant association of cyclin D1 single nucleotide
polymorphisms with oral cancer in taiwan. Anticancer Res.
31:227–231. 2011.PubMed/NCBI
|
|
36
|
Akkiz H, Bayram S, Bekar A, Akgöllü E and
Ozdil B: Cyclin D1 G870A polymorphism is associated with an
increased risk of hepatocellular carcinoma in the Turkish
population: case-control study. Cancer Epidemiol. 34:298–302. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cai W, Wang ZT, Zhong J and Zhang Y: Lack
of association between Cyclin D1 gene G870A polymorphism and
esophageal cancer: evidence from a meta-analysis. Genet Mol Res.
12:6636–6645. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhuo W, Zhang L, Wang Y, Zhu B and Chen Z:
Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer
among Asians. Cancer Invest. 30:630–636. 2012. View Article : Google Scholar : PubMed/NCBI
|
